Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic drugs like NSAIDs and contrast agents.
Acute Kidney Injury (AKI) is identified by either an increase of 0.3 mg/dL or more in serum creatinine within 48 hours or a 1.5-fold rise in baseline creatinine over seven days. A reduced urine output, less than 0.5 mL/kg/hour for six hours, is also a key diagnostic marker. Though potentially reversible, AKI has a high mortality rate, especially in hospitalized patients. Classification:
The RIFLE classification system is used to assess the severity of AKI and guide treatment. RIFLE stands for Risk, Injury, Failure, Loss, and End-Stage Kidney Disease (ESKD). It has three severity stages followed by two outcome stages.
AKI, if untreated, can lead to chronic kidney disease (CKD) or ESKD. Early detection using the RIFLE system is crucial to improving patient outcomes.
Acute Kidney Injury or AKI is a rapid decline in kidney function that develops over hours to days. Common causes include dehydration, sepsis, or exposure to nephrotoxic substances.
AKI is classified using the RIFLE system, comprising three severity stages: Risk, Injury, and Failure, followed by two outcome stages: Loss and End-Stage Kidney Disease or ESKD.
The first stage, Risk, is marked by a one-and-a-half-times increase in serum creatinine or a 25% decrease in the glomerular filtration rate, or GFR.
The next stage, Injury, involves a 2 times increase in serum creatinine or a 50% GFR reduction.
The third stage, Failure, involves a 3 times increase in serum creatinine or a GFR reduction of more than 75%.
The final stages, Loss and ESKD, describe irreversible damage.
Loss refers to a sustained loss of kidney function for more than four weeks, while ESKD indicates complete kidney failure that persists for more than three months and may require dialysis or transplantation for survival.